Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

SN 38, Tocris Bioscience™
GREENER_CHOICE

Catalog No. 268450
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

DNA topoisomerase I inhibitor; antitumor

Active metabolite of CPT-11 (Cat. No. 2688) that inhibits DNA topoisomerase I (IC50 values are 0.74 and 1.9 μM in P388 and Ehrlich cells respectively). Inhibits DNA and RNA synthesis (IC50 values are 0.077 and 1.3 μM respectively) but does not affect protein synthesis. Displays potent antitumor activity against a range of human tumor cell lines (IC50 values are 3.3, 13, 19 and 22 nM for HCT-116, BEL-7402, HL60 and HELA cells respectively).

Chemical Identifiers

CAS 86639-52-3
Molecular Formula C22H20N2O5
Molecular Weight (g/mol) 392.411
InChI Key FJHBVJOVLFPMQE-QFIPXVFZSA-N
Synonym 7-ethyl-10-hydroxycamptothecin, sn 38 lactone, 7-ethyl-10-hydroxy-camptothecin, 10-hydroxy-7-ethylcamptothecin, 7-ethyl-10-hydroxycamptothecine, le-sn38, 7-ethyl-10-hydroxy-20 s-camptothecin, captothecin, 7-ethyl-10-hydroxy, s-4,11-diethyl-4,9-dihydroxy-1h-pyrano 3',4':6,7 indolizino 1,2-b quinoline-3,14 4h,12h-dione, 7-ethyl-10-hydroxy camptothecin
PubChem CID 104842
ChEBI CHEBI:8988
SMILES CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O

Specifications

Quantity 50 mg
Formula Weight 392.4
Percent Purity >98%
Chemical Name or Material SN 38
Recommended Storage Store at +4°C
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.